Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Breast Neoplasms × CP protocol × Clear all

Phase

Status

Completed 3 Not yet recruiting 2 Unknown 1 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Non Small Cell Lung Carcinoma NSCLC 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Triple Negative Breast Neoplasms 1 Ovarian Diseases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Genital Neoplasms, Female 1 Genital Diseases, Female 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Endocrine System Diseases 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1

Interventions

Paclitaxel 63 Letrozole 55 Fulvestrant 53 Trastuzumab 51 palbociclib 41 pembrolizumab 40 Carboplatin 38 Anastrozole 37 Cyclophosphamide 36 pertuzumab 35 exemestane 25 Capecitabine 25 Tamoxifen 24 abemaciclib 23 Radiotherapy 22 Docetaxel 22 ribociclib 20 olaparib 20 Doxorubicin 19 Magnetic Resonance Spectroscopy 17 Epirubicin 17 Surveys and Questionnaires 16 durvalumab 15 trastuzumab deruxtecan 14 Exercise 14 Alpelisib 14 130-nm albumin-bound paclitaxel 14 Taxes 13 Mastectomy, Segmental 12 Gonadotropin-Releasing Hormone 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03609047 2024-01-24

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡